Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation

被引:0
作者
Xing, L. Y. [1 ]
Barcella, C. A. [1 ]
Sindet-Pedersen, C. [1 ]
Bonde, A. N. [1 ]
Gislason, G. [1 ]
Olesen, J. B. [1 ]
机构
[1] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P3841
引用
收藏
页码:819 / 819
页数:1
相关论文
共 50 条
[31]   Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis [J].
Capodanno, Davide ;
Di Maio, Marco ;
Greco, Antonio ;
Bhatt, Deepak L. ;
Gibson, C. Michael ;
Goette, Andreas ;
Lopes, Renato D. ;
Mehran, Roxana ;
Vranckx, Pascal ;
Angiolillo, Dominick J. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (16)
[32]   Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes [J].
Rubboli, Andrea .
ITALIAN JOURNAL OF MEDICINE, 2013, 7 :22-28
[33]   Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation [J].
van den Dries, Carline J. ;
Pajouheshnia, Romin ;
van den Ham, Hendrika A. ;
Souverein, Patrick ;
Moons, Karel G. M. ;
Hoes, Arno W. ;
Geersing, Geert-Jan ;
van Doorn, Sander .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) :751-761
[34]   Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation [J].
Jelonek, Olga ;
Gorczyca, Iwona ;
Baczek, Michal ;
Kosmider, Pawel ;
Wozakowska-Kaplon, Beata .
KARDIOLOGIA POLSKA, 2018, 76 (07) :1073-1080
[35]   Dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: A Danish nationwide cohort study [J].
Xing, Lucas Yixi ;
Barcella, Carlo Alberto ;
Sindet-Pedersen, Caroline ;
Bonde, Anders Nissen ;
Gislason, Gunnar Hilmar ;
Olesen, Jonas Bjerring .
THROMBOSIS RESEARCH, 2019, 178 :101-109
[36]   Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK [J].
Garcia Rodriguez, Luis Alberto ;
Martin-Perez, Mar ;
Vora, Pareen ;
Roberts, Luke ;
Balabanova, Yanina ;
Brobert, Gunnar ;
Fatoba, Samuel ;
Suzart-Woischnik, Kiliana ;
Schaefer, Bernhard ;
Ruigomez, Ana .
BMJ OPEN, 2019, 9 (09)
[37]   Non-vitamin K antagonist oral anticoagulants in the treatment of coronary and peripheral atherosclerosis [J].
Witkowski, Adam ;
Barylski, Marcin ;
Filipiak, Krzysztof J. ;
Gierlotka, Marek ;
Legutko, Jacek ;
Lesiak, Maciej ;
Stepinska, Janina ;
Wojakowski, Wojciech .
KARDIOLOGIA POLSKA, 2019, 77 (04) :490-504
[38]   The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly [J].
Patti, Giuseppe ;
Cavallari, Ilaria ;
Hanon, Olivier ;
De Caterina, Raffaele .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 :118-124
[39]   Clinical Significance of Non-Vitamin K Antagonist Oral Anticoagulants in the Management of Atrial Fibrillation [J].
Santarpia, Giuseppe ;
Curcio, Antonio ;
Sibilio, Gerolamo ;
Indolfi, Ciro .
CIRCULATION JOURNAL, 2015, 79 (05) :914-923
[40]   Patient Guide for Taking the Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation [J].
Lane, Deirdre A. ;
Wood, Kathryn .
CIRCULATION, 2015, 131 (16) :E412-E415